Santhera Pharmaceuticals Holding AG SPHDF Stock
Santhera Pharmaceuticals Holding AG Price Chart
Santhera Pharmaceuticals Holding AG SPHDF Financial and Trading Overview
| Santhera Pharmaceuticals Holding AG stock price | 23.25 USD |
| Previous Close | 23.25 USD |
| Open | 22.85 USD |
| Bid | 22.7 USD x 10000 |
| Ask | 24.75 USD x 10000 |
| Day's Range | 22.85 - 22.85 USD |
| 52 Week Range | 12.28 - 23.25 USD |
| Volume | 100 USD |
| Avg. Volume | 239 USD |
| Market Cap | 337.73M USD |
| Beta (5Y Monthly) | -0.341 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -4.83 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
SPHDF Valuation Measures
| Enterprise Value | 337.91M USD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 4.3755994 |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | 4.378 |
| Enterprise Value/EBITDA | -10.386 |
Trading Information
Santhera Pharmaceuticals Holding AG Stock Price History
| Beta (5Y Monthly) | -0.341 |
| 52-Week Change | 57.62% |
| S&P500 52-Week Change | 27.69% |
| 52 Week High | 23.25 USD |
| 52 Week Low | 12.28 USD |
| 50-Day Moving Average | 21.54 USD |
| 200-Day Moving Average | 17.15 USD |
SPHDF Share Statistics
| Avg. Volume (3 month) | 239 USD |
| Avg. Daily Volume (10-Days) | 0 USD |
| Shares Outstanding | 14.53M |
| Float | 11.07M |
| Short Ratio | N/A |
| % Held by Insiders | 15.25% |
| % Held by Institutions | 9.51% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:10 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2025 |
| Most Recent Quarter (mrq) | December 31, 2025 |
| Next Fiscal Year End | December 31, 2026 |
Profitability
| Profit Margin | -63.78% |
| Operating Margin (ttm) | -4.076% |
| Gross Margin | 19.65% |
| EBITDA Margin | -42.15% |
Management Effectiveness
| Return on Assets (ttm) | -15.64% |
| Return on Equity (ttm) | -620.023% |
Income Statement
| Revenue (ttm) | 77.19M USD |
| Revenue Per Share (ttm) | 5.93 USD |
| Quarterly Revenue Growth (yoy) | 112.70% |
| Gross Profit (ttm) | 15.17M USD |
| EBITDA | -32536000 USD |
| Net Income Avi to Common (ttm) | -49236000 USD |
| Diluted EPS (ttm) | -4.8 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 22.44M USD |
| Total Cash Per Share (mrq) | 1.68 USD |
| Total Debt (mrq) | 48.95M USD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 1.291 |
| Book Value Per Share (mrq) | -0.2535172 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -34763000 USD |
| Levered Free Cash Flow (ttm) | -35633000 USD |
Profile of Santhera Pharmaceuticals Holding AG
| Country | United States |
| State | N/A |
| City | Pratteln |
| Address | Hohenrainstrasse 24 |
| ZIP | 4133 |
| Phone | 41 61 906 89 50 |
| Website | https://www.santhera.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 93 |
Santhera Pharmaceuticals Holding AG, a specialty pharmaceutical company, together with its subsidiaries, develops and sells medicines for rare neuromuscular and pulmonary diseases with high unmet medical need in the Europe, North America, and Asia. The company's lead pipeline candidate includes Vamorolone, which is developed for the treatments of Duchenne muscular dystrophy. Santhera Pharmaceuticals Holding AG was founded in 2004 and is based in Pratteln, Switzerland.
Q&A For Santhera Pharmaceuticals Holding AG Stock
What is a current SPHDF stock price?
Santhera Pharmaceuticals Holding AG SPHDF stock price today per share is 23.25 USD.
How to purchase Santhera Pharmaceuticals Holding AG stock?
You can buy SPHDF shares on the OTC Markets OTCPK exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Santhera Pharmaceuticals Holding AG?
The stock symbol or ticker of Santhera Pharmaceuticals Holding AG is SPHDF.
Which industry does the Santhera Pharmaceuticals Holding AG company belong to?
The Santhera Pharmaceuticals Holding AG industry is Biotechnology.
How many shares does Santhera Pharmaceuticals Holding AG have in circulation?
The max supply of Santhera Pharmaceuticals Holding AG shares is 14.53M.
What is Santhera Pharmaceuticals Holding AG Price to Earnings Ratio (PE Ratio)?
Santhera Pharmaceuticals Holding AG PE Ratio is now.
What was Santhera Pharmaceuticals Holding AG earnings per share over the trailing 12 months (TTM)?
Santhera Pharmaceuticals Holding AG EPS is -4.83 USD over the trailing 12 months.
Which sector does the Santhera Pharmaceuticals Holding AG company belong to?
The Santhera Pharmaceuticals Holding AG sector is Healthcare.